Asymmetric dimethylarginine (ADMA): Is really a biomarker for cardiovascular prognosis?

被引：10
|
作者：
Tousoulis, Dimitris [1 ]
Siasos, Gerasimos [1 ,2 ]
Oikonomou, Evangelos [1 ]
Stougianos, Pavlos [2 ]
Papageorgiou, Nikolaos [1 ]
机构：
[1] Univ Athens, Sch Med, Hippokrat Hosp, Cardiol Dept 1, GR-11527 Athens, Greece
[2] Univ Athens, Sch Med, Dept Biol Chem, GR-11527 Athens, Greece
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2011年 / 153卷 / 02期
关键词：
Asymmetric dimethylarginine; Biomarker; Cardiovascular disease; Atherosclerosis; CORONARY-ARTERY-DISEASE; STAGE RENAL-DISEASE; L-ARGININE; PLASMA-LEVELS; RISK; EVENTS; MORTALITY; MARKER; DEATH;
D O I：
10.1016/j.ijcard.2011.08.070
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：123 / 125
页数：3
相关论文
共 50 条
  • [1] Asymmetric Dimethylarginine (ADMA): A Promising Biomarker for Cardiovascular Disease?
    Bouras, Georgios
    Deftereos, Spyridon
    Tousoulis, Dimitrios
    Giannopoulos, Georgios
    Chatzis, Georgios
    Tsounis, Dimitrios
    Cleman, Michael W.
    Stefanadis, Christodoulos
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (02) : 180 - 200
  • [2] Asymmetric Dimethylarginine (ADMA) in cardiovascular and renal disease
    Alpoim, Patricia Nessralla
    Nunes Sousa, Leticia Parreiras
    Lucas Mota, Ana Paula
    Alves Rios, Danyelle Romana
    SantAna Dusse, Luci Maria
    CLINICA CHIMICA ACTA, 2015, 440 : 36 - 39
  • [3] Asymmetric dimethylarginine (ADMA) as an early cardiovascular biomarker in a children population exposed to inorganic arsenic
    Osorio-Yanez, C.
    Ayllon-Vergara, J. C.
    Hernandez-Castellanos, E.
    Arreola-Mendoza, L.
    Melgar-Paniagua, E. M.
    De Vizcaya-Ruiz, A.
    Aguilar-Madrid, G.
    Del Razo, L. M.
    TOXICOLOGY LETTERS, 2011, 205 : S67 - S67
  • [4] THE RELATIONSHIP OF ASYMMETRIC DIMETHYLARGININE (ADMA) AND PROGNOSIS FACTORS IN IGA NEPHROPATHY
    Kim, Hyung Jong
    Lee, Jung Eun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 193 - 193
  • [5] Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move
    Zoccali, C
    JOURNAL OF HYPERTENSION, 2006, 24 (04) : 611 - 619
  • [6] The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
    Sibal, Latika
    Agarwal, Sharad C.
    Home, Philip D.
    Boger, Rainer H.
    CURRENT CARDIOLOGY REVIEWS, 2010, 6 (02) : 82 - 90
  • [7] Biological Functional Relevance of Asymmetric Dimethylarginine (ADMA) in Cardiovascular Disease
    Franceschelli, Sara
    Ferrone, Alessio
    Pesce, Mirko
    Riccioni, Graziano
    Speranza, Lorenza
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (12): : 24412 - 24421
  • [8] Asymmetric dimethylarginine (ADMA):: A novel risk marker in cardiovascular medicine and beyond
    Böger, RH
    ANNALS OF MEDICINE, 2006, 38 (02) : 126 - 136
  • [9] Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality
    Böger, RH
    Maas, R
    Schulze, F
    Schwedhelm, E
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (10) : 1124 - 1129
  • [10] Asymmetric dimethylarginine (ADMA) is identified as a potential biomarker of insulin resistance in skeletal muscle
    Woojung Lee
    Hyo Jung Lee
    Han Byul Jang
    Hyo-Jin Kim
    Hyo-Jeong Ban
    Kwang Youl Kim
    Moon Suk Nam
    Joo Sun Choi
    Kyung-Tae Lee
    Seong Beom Cho
    Sang Ick Park
    Hye-Ja Lee
    Scientific Reports, 8
12345